NCT03656172View on ClinicalTrials.gov

Interest of Reticulocyte Haemoglobin Content (RET-he) in Management of Functional Anemia for Patient With Solid Tumor

CompletedOBSERVATIONAL
Enrollment

54

Participants

Timeline

Start Date

May 4, 2017

Primary Completion Date

May 11, 2020

Study Completion Date

May 11, 2020

Conditions
Solid Tumor, AdultAnemia Deficiency
Interventions
BIOLOGICAL

Haemoglobin measure

Haemoglobin measure before and one month after standard iron treatment

Trial Locations (1)

44805

Institut de Cancérologie de l'Ouest, Saint-Herblain

All Listed Sponsors
lead

Institut Cancerologie de l'Ouest

OTHER

NCT03656172 - Interest of Reticulocyte Haemoglobin Content (RET-he) in Management of Functional Anemia for Patient With Solid Tumor | Biotech Hunter | Biotech Hunter